In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

According to the team’s results, the BrainGate array wired directly to motor neurons offered a “sixfold improvement” on the ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.

A clinical study using mushrooms containing the psychoactive psilocybin to treat methamphetamine addiction has just completed its first phase of trials. Over the past month the first cohort of ...

First published in 1999, this revised edition includes results from a phase 4 clinical trial that once again proved the efficacy ... oral disinfectant in a stick pouch form. The company explained that ...

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for ...

Psychedelics may have a positive effect on the mental health of patients with cancer, as one expert explained in an interview ...

Context Therapeutics has dosed the first subject in the Phase I trial of CTIM-76, targeting claudin 6 (CLDN6)-positive ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...